腫瘍死滅因子α誘発タンパク質3 (TNFAIP3) は,冠動脈疾患 (CHD) を独立して予測することができる
Anyi Wang1, Mengmeng Ren2, Han Sun2
1Shandong University of Traditional Chinese Medicine, Jinan, Shandong, P.R. China.
Acta cardiologica
|September 4, 2025
まとめ
腫瘍死滅因子アルファ誘導タンパク質3 (TNFAIP3) 濃度は冠動脈疾患 (CHD) の患者で低い. 下部TNFAIP3は心臓病の独立した予測因子であり,診断のための臨床的有用性を示唆しています.
科学分野:
- 心血管医学
- 免疫学
- バイオマーカーの発見
背景:
- 炎症は冠動脈疾患 (CHD) と関連しています.
- 腫瘍死滅因子アルファ誘導タンパク質3 (TNFAIP3) は,抗炎症タンパク質である.
- TNFAIP3のCHDリスクに対する役割は,以前は知られていなかった.
研究 の 目的:
- TNFAIP3レベルとCHDの関連性を調査する.
- TNFAIP3が心臓病の独立予測因子であるかどうかを判断する.
- TNFAIP3の心臓病の診断の可能性を評価する.
主な方法:
- 236人の患者でTNFAIP3レベルを測定するために,酵素結合免疫検査 (ELISA) を使用した.
- 患者は心臓病 (n=162) と対照群 (n=74) に分類された.
- 傾向スコアマッチングとロジスティック回帰分析を使用した.
主要な成果:
- TNFAIP3の濃度は,傾向スコアが一致する前と後の両方で,対照群と比較して,著しく低かった.
- TNFAIP3は心臓病との負の相関を示し,独立した予測因子として特定されました.
- 受容器の動作特性 (ROC) 曲線解析は,CHDの発達におけるTNFAIP3の強力な予測値を示した (AUC=0. 957).
結論:
- TNFAIP3の値低下は心臓病と関連しています.
- TNFAIP3はCHDの独立した予測因子として機能します.
- TNFAIP3の臨床測定は,心臓病の診断に役立ちます.
さらに関連する動画
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
523
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
212
関連する概念動画
01:30Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
01:30Coronary Artery Disease III: Clinical Manifestations
31
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
31
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
213
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213
01:30Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
01:26Coronary Artery Disease II: Pathophysiology
33
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K